Latest News about CRVS
Recent news which mentions CRVS
12 Health Care Stocks Moving In Thursday's After-Market Session
February 08, 2024
From Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
December 11, 2023
From Benzinga
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 07, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 06, 2023
From Benzinga
Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer
August 18, 2023
Tickers
CRVS
From Benzinga
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 10, 2023
From Benzinga
From Benzinga
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 15, 2023
From Benzinga
3 High-Potential Penny Stocks to Buy Now
May 31, 2023
From InvestorPlace
From Benzinga
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 17, 2023
From Benzinga
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
From Benzinga
From Benzinga
7 High-Potential Penny Stocks in the Biotech Sector
May 04, 2023
Tags
Market News
PGEN
NASDAQ:CUE,NASDAQ:SANA,NASDAQ:PGEN,NASDAQ:ATOS,NASDAQ:BLRX,NASDAQ:CRVS,NASDAQ:ARDX
From InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for April
April 04, 2023
From InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 04, 2023
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 21, 2023
From Benzinga
From Benzinga
From Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2022
October 07, 2022
From Benzinga
Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer
September 27, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
